NRC (NRC Health Common Stock) Stock Analysis - Politician Trades
NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of May 21, 2026, NRC trades at $19.50 with a market cap of $422.34M and a P/E ratio of 0.38. NRC moved +2.77% today. Year to date, NRC is +2.45%; over the trailing twelve months it is +39.57%. Its 52-week range spans $9.76 to $22.99. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded NRC stock?
Rallies tracks politician and congressional stock disclosures for NRC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
HARRISON SHANE R bought 8.00K (~$98.16K) on Feb 17, 2026.
Freeman Jordan Nicole bought 771 (~$10.00K) on Jul 31, 2025.
BEANS PATRICK E bought 2.50K (~$33.97K) on May 12, 2025.
NRC Analyst Consensus
NRC analyst coverage data. Average price target: $0.00.
Common questions about NRC
Which politicians traded NRC stock?
Rallies tracks politician and congressional stock disclosures for NRC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in NRC?
Yes. Rallies tracks politician and congressional stock disclosures for NRC, including reported purchases, sales, dates, owners, and trade amounts when available.
Is NRC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NRC. It does not provide personalized investment advice.